Literature DB >> 15308683

Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice.

Keiji Iida1, Emina Itoh, Dong-Sun Kim, Juan P del Rincon, Karen T Coschigano, John J Kopchick, Michael O Thorner.   

Abstract

Two muscle insulin-like growth factor-I (IGF-I) mRNA splice variants (IGF-IEa and IGF-IEb) have been identified in rodents. IGF-IEb, also called mechano growth factor (MGF) has been found to be upregulated by exercise or muscle damage. Growth hormone (GH) is the principal regulator of IGF-I expression in several tissues including skeletal muscle. Therefore, we investigated the effect of chronic GH excess or disruption of GH receptor (GHR) signalling, and the acute effect of GH administration on expression of muscle IGF-I isoforms using transgenic mice that express bovine GH (bGH), GHR gene-disrupted (GHR-/-) mice and GH-deficient lit/lit mice before and after exogenous GH administration. MGF mRNA in skeletal muscle was increased in bGH mice whereas it was decreased in GHR-/- mice compared with control animals. Exogenous GH administration to dwarf lit/lit mice significantly increased muscle MGF but not IGF-IEa mRNA 4 h after treatment. Twelve hours after GH treatment, both MGF and IGF-IEa mRNAs in muscle were increased compared with vehicle-treated lit/lit mice. In contrast in GH-sufficient lit/+ mice, both MGF and IGF-IEa mRNAs were increased 4 h after and returned to the basal level 12 h after GH treatment. Hepatic IGF-I isoforms were regulated in parallel by GH. Thus, our results demonstrated that: (1) MGF mRNA in skeletal muscle is expressed in parallel with GH action; (2) MGF mRNA in muscle is produced preferentially in the situation of GH deficiency in contrast to the pattern in the GH-sufficient state; and (3) the induction of IGF-I isoforms by GH is tissue-specific.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308683      PMCID: PMC1665252          DOI: 10.1113/jphysiol.2004.069500

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.

Authors:  C L Sadowski; T T Wheeler; L H Wang; H B Sadowski
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

2.  Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload.

Authors:  V Owino; S Y Yang; G Goldspink
Journal:  FEBS Lett       Date:  2001-09-14       Impact factor: 4.124

3.  Effects of hypophysectomy and growth hormone administration on the mRNA levels of collagen I, III and insulin-like growth factor-I in rat skeletal muscle.

Authors:  V J Wilson; M Rattray; C R Thomas; B H Moreland; D Schulster
Journal:  Growth Horm IGF Res       Date:  1998-12       Impact factor: 2.372

4.  Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2.

Authors:  Y Chen; M Hughes-Fulford
Journal:  Int J Cancer       Date:  2001-01-01       Impact factor: 7.396

5.  The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men.

Authors:  M Hameed; K H W Lange; J L Andersen; P Schjerling; M Kjaer; S D R Harridge; G Goldspink
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

6.  Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.

Authors:  Keiji Iida; Juan P Del Rincon; Dong-Sun Kim; Emina Itoh; Ralf Nass; Karen T Coschigano; John J Kopchick; Michael O Thorner
Journal:  Endocrinology       Date:  2004-01-15       Impact factor: 4.736

7.  Early regeneration of whole skeletal muscle grafts is unaffected by overexpression of IGF-1 in MLC/mIGF-1 transgenic mice.

Authors:  Thea Shavlakadze; Marilyn Davies; Jason D White; Miranda D Grounds
Journal:  J Histochem Cytochem       Date:  2004-07       Impact factor: 2.479

8.  Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

Authors:  A J D'Ercole; A D Stiles; L E Underwood
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Different levels of neuroprotection by two insulin-like growth factor-I splice variants.

Authors:  Michael Aperghis; Ian P Johnson; John Cannon; Shi-Yu Yang; Geoffrey Goldspink
Journal:  Brain Res       Date:  2004-05-29       Impact factor: 3.252

10.  Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.

Authors:  D R Clemmons; L E Underwood; J J Van Wyk
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

View more
  10 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats.

Authors:  Akihiko Yamaguchi; Takahiko Fujikawa; Seita Shimada; Isao Kanbayashi; Masaru Tateoka; Hideaki Soya; Hidekatsu Takeda; Isao Morita; Kunio Matsubara; Toshihiro Hirai
Journal:  Pflugers Arch       Date:  2006-08-29       Impact factor: 3.657

Review 3.  Running on empty: how p53 controls INS/IGF signaling and affects life span.

Authors:  Heidi Scrable; Silvia Medrano; Erica Ungewitter
Journal:  Exp Gerontol       Date:  2008-06-13       Impact factor: 4.032

4.  Skeletal muscle growth defect in human growth hormone transgenic rat is accompanied by phenotypic changes in progenitor cells.

Authors:  Shingo Shibata; Chiori Ueno; Tsuyoshi Ito; Keitaro Yamanouchi; Takashi Matsuwaki; Masugi Nishihara
Journal:  Age (Dordr)       Date:  2010-01-23

5.  Expression of insulin-like growth factor 1 isoforms in the rabbit oculomotor system.

Authors:  Cheng-Yuan Feng; Christopher S von Bartheld
Journal:  Growth Horm IGF Res       Date:  2011-06-23       Impact factor: 2.372

Review 6.  Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

Authors:  Edward O List; Lucila Sackmann-Sala; Darlene E Berryman; Kevin Funk; Bruce Kelder; Elahu S Gosney; Shigeru Okada; Juan Ding; Diana Cruz-Topete; John J Kopchick
Journal:  Endocr Rev       Date:  2010-12-01       Impact factor: 19.871

7.  Chronic alterations in growth hormone/insulin-like growth factor-I signaling lead to changes in mouse tendon structure.

Authors:  R H Nielsen; N M Clausen; P Schjerling; J O Larsen; T Martinussen; E O List; J J Kopchick; M Kjaer; K M Heinemeier
Journal:  Matrix Biol       Date:  2013-09-28       Impact factor: 11.583

8.  The effect of training volume and intensity on improvements in muscular strength and size in resistance-trained men.

Authors:  Gerald T Mangine; Jay R Hoffman; Adam M Gonzalez; Jeremy R Townsend; Adam J Wells; Adam R Jajtner; Kyle S Beyer; Carleigh H Boone; Amelia A Miramonti; Ran Wang; Michael B LaMonica; David H Fukuda; Nicholas A Ratamess; Jeffrey R Stout
Journal:  Physiol Rep       Date:  2015-08

9.  Chronic doxorubicin administration impacts satellite cell and capillary abundance in a muscle-specific manner.

Authors:  Andrew C D'Lugos; Christopher S Fry; Jordan C Ormsby; Kaylin R Sweeney; Camille R Brightwell; Taben M Hale; Rayna J Gonzales; Siddhartha S Angadi; Chad C Carroll; Jared M Dickinson
Journal:  Physiol Rep       Date:  2019-04

10.  Surface modification of electrospun fibers with mechano-growth factor for mitigating the foreign-body reaction.

Authors:  Yang Song; Linhao Li; Weikang Zhao; Yuna Qian; Lili Dong; Yunnan Fang; Li Yang; Yubo Fan
Journal:  Bioact Mater       Date:  2021-03-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.